Clinical Trial Update: ArtemiCoffee in Patients With Rising PSA [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ArtemiCoffee in prostate cancer patients with rising PSA, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ArtemiCoffee

Snippet

Sponsor: Zin W Myint | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING